Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients

K Taki1, F Takayama, Y Tsuruta

  • 1Department of Clinical Preventive Medicine, Nagoya University Hospital, Nagoya, Japan.

Insights

Oxidative stress and advanced glycation end products (AGEs) like pentosidine, alongside traditional risk factors, are linked to coronary artery calcification in hemodialysis patients. These factors may contribute to the development of calcification in this high-risk group.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Coronary artery calcification (CAC) is a marker of atherosclerotic vascular disease severity and a predictor of cardiovascular events in hemodialysis (HD) patients.
  • HD patients experience elevated oxidative stress and advanced glycation end products (AGEs), contributing to cardiovascular complications.

Purpose of the Study:

  • To investigate the association between oxidative stress, AGEs, traditional cardiovascular risk factors, and coronary artery calcification score (CACS) in HD patients.

Main Methods:

  • A cross-sectional study involving 225 HD patients.
  • Coronary artery calcification score (CACS) was assessed using multi-detector row computed tomography.
  • Statistical analyses included correlation and forward stepwise multiple linear regression.

Main Results:

  • Age, systolic blood pressure, calcium, calcium x phosphate, malondialdehyde, lipid peroxides, and pentosidine showed significant positive correlations with CACS.
  • Independent predictors of CACS were age, systolic blood pressure, lipid peroxides, calcium, and pentosidine.
  • History of coronary artery disease and diabetes mellitus were associated with high CACS.

Conclusions:

  • Oxidative stress (lipid peroxides) and AGEs (pentosidine) are independently associated with extensive coronary artery calcification in HD patients, beyond traditional risk factors.
  • Lipid peroxidation and glycoxidation are implicated in the pathogenesis of coronary artery calcification in this population.
  • These findings highlight potential therapeutic targets for reducing cardiovascular risk in HD patients.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...